Syneron Candela Goes Private In $400M Deal With Apax
JULY 18, 2017
Irvine-based aesthetic medical device developer Syneron Medical announced late Monday evening that it has become a private company, in a $400M go-private deal with Apax Partners. According to Syneron Medical, funds advised by Apax Partners paid $11.00 per share in cash for the company. The deal had originally announced on April 3rd. As part of the go-private deal, Syneron said that Geoffrey Crouse has been appointed CEO of the company, and also has joined its board.